当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2019年第11期
编号:13344028
高压氧科血流感染病原菌分布及耐药分析(4)
http://www.100md.com 2019年4月15日 《中国医药导报》 2019年第11期
     [15] Shu LB,Lu Q,Sun RH,et al. Prevalence and phenotypic characterization of carbapenem-resistant Klebsiella pneumoniaestrains recovered from sputum and fecal samples of ICU patients in Zhejiang Province,China [J]. Infect Drug Resist,2018,18(12):11-18.

    [16] Calia C,Pazzani C,Oliva M,et al. Carbapenemases-producing Klebsiella pneumoniae in hospitals of two regions of Southern Italy [J]. APMIS,2017,125(5):491-498.

    [17] 梁亮,农生洲,刘晓春,等.2014-2016年广西地区克雷伯菌屬细菌耐药性监测[J].中华医院感染学杂志,2018, 28(20):3050-3055.

    [18] 张慧,王健,吴晓燕,等.159株耐碳青霉烯类肠杆菌科细菌的临床特征和耐药性分析[J].检验医学与临床,2018, 15(20):3050-3055.

    [19] 谭雪梅.肺炎克雷伯菌耐药表型的分布及其耐药性临床观察[J].中外医学研究,2018,16(2):76-77.

    [20] Cunha BA,Baron J,Cunha CB. Monotherapy with high-dose once-daily tigecycline is highly effective against Acinetobacter baumanii and other multidrug-resistant(MDR)gram-negative bacilli (GNB)[J]. Int J Antimicrob Agents,2018,52(1):119-120.

    [21] Patil HV,Patil VC,Ramteerthkar MN,et al. Central venous catheter-related bloodstream infections in the intensive care unit [J]. Indian J Crit Care Med,2011,15(4):213-223.

    (收稿日期:2019-01-13 本文编辑:苏 畅), http://www.100md.com(王海东 张禹 杨艳)
上一页1 2 3 4